世界の男性不妊治療市場 2019年

【英語タイトル】Global Male Infertility Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB04098)・商品コード:QYR20FB04098
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、男性不妊治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、DNA断片化技術、酸化ストレス分析、顕微鏡検査、精子凝集、コンピューター支援精液分析、精子浸透アッセイ、その他に、用途別には、病院、診療所、その他にセグメント区分し、男性不妊治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・男性不妊治療の世界市場概要
・男性不妊治療の製造コスト構成分析
・男性不妊治療の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・男性不妊治療の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・男性不妊治療のセグメント分析(種類別)
(DNA断片化技術、酸化ストレス分析、顕微鏡検査、精子凝集、コンピューター支援精液分析、精子浸透アッセイ、その他)
・男性不妊治療のセグメント分析(用途別)
(病院、診療所、その他)
・男性不妊治療の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(EMD Sereno、Aytu BioScience、Bayer、Cadila、Intas Pharma、Halotech DNA、SCSA diagnostics、Andrology Solutions)
・男性不妊治療の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

According to Word Health Organization, ‘Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year’. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwillingly childless. Approximately 90% of male infertility cases are seen mainly due to low sperm counts, and poor sperm quality. The remaining cases of male infertility can be caused by a number of factors including anatomical problems, hormonal imbalances, and genetic defects.
The global Male Infertility Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Male Infertility Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Male Infertility Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Male Infertility Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Male Infertility Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
EMD Sereno
Aytu BioScience
Bayer
Cadila
Intas Pharma
Halotech DNA
SCSA diagnostics
Andrology Solutions

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Others

Segment by Application
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Male Infertility Treatment
1.1 Definition of Male Infertility Treatment
1.2 Male Infertility Treatment Segment by Type
1.2.1 Global Male Infertility Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 DNA Fragmentation Technique
1.2.3 Oxidative Stress Analysis
1.2.4 Microscopic Examination
1.2.5 Sperm Agglutination
1.2.6 Computer Assisted Semen Analysis
1.2.7 Sperm Penetration Assay
1.2.8 Others
1.3 Male Infertility Treatment Segment by Applications
1.3.1 Global Male Infertility Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Male Infertility Treatment Overall Market
1.4.1 Global Male Infertility Treatment Revenue (2014-2025)
1.4.2 Global Male Infertility Treatment Production (2014-2025)
1.4.3 North America Male Infertility Treatment Status and Prospect (2014-2025)
1.4.4 Europe Male Infertility Treatment Status and Prospect (2014-2025)
1.4.5 China Male Infertility Treatment Status and Prospect (2014-2025)
1.4.6 Japan Male Infertility Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Male Infertility Treatment Status and Prospect (2014-2025)
1.4.8 India Male Infertility Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Male Infertility Treatment
2.3 Manufacturing Process Analysis of Male Infertility Treatment
2.4 Industry Chain Structure of Male Infertility Treatment

3 Development and Manufacturing Plants Analysis of Male Infertility Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Male Infertility Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Male Infertility Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Male Infertility Treatment Production and Capacity Analysis
4.2 Male Infertility Treatment Revenue Analysis
4.3 Male Infertility Treatment Price Analysis
4.4 Market Concentration Degree

5 Male Infertility Treatment Regional Market Analysis
5.1 Male Infertility Treatment Production by Regions
5.1.1 Global Male Infertility Treatment Production by Regions
5.1.2 Global Male Infertility Treatment Revenue by Regions
5.2 Male Infertility Treatment Consumption by Regions
5.3 North America Male Infertility Treatment Market Analysis
5.3.1 North America Male Infertility Treatment Production
5.3.2 North America Male Infertility Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Male Infertility Treatment Import and Export
5.4 Europe Male Infertility Treatment Market Analysis
5.4.1 Europe Male Infertility Treatment Production
5.4.2 Europe Male Infertility Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Male Infertility Treatment Import and Export
5.5 China Male Infertility Treatment Market Analysis
5.5.1 China Male Infertility Treatment Production
5.5.2 China Male Infertility Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Male Infertility Treatment Import and Export
5.6 Japan Male Infertility Treatment Market Analysis
5.6.1 Japan Male Infertility Treatment Production
5.6.2 Japan Male Infertility Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Male Infertility Treatment Import and Export
5.7 Southeast Asia Male Infertility Treatment Market Analysis
5.7.1 Southeast Asia Male Infertility Treatment Production
5.7.2 Southeast Asia Male Infertility Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Male Infertility Treatment Import and Export
5.8 India Male Infertility Treatment Market Analysis
5.8.1 India Male Infertility Treatment Production
5.8.2 India Male Infertility Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Male Infertility Treatment Import and Export

6 Male Infertility Treatment Segment Market Analysis (by Type)
6.1 Global Male Infertility Treatment Production by Type
6.2 Global Male Infertility Treatment Revenue by Type
6.3 Male Infertility Treatment Price by Type

7 Male Infertility Treatment Segment Market Analysis (by Application)
7.1 Global Male Infertility Treatment Consumption by Application
7.2 Global Male Infertility Treatment Consumption Market Share by Application (2014-2019)

8 Male Infertility Treatment Major Manufacturers Analysis
8.1 EMD Sereno
8.1.1 EMD Sereno Male Infertility Treatment Production Sites and Area Served
8.1.2 EMD Sereno Product Introduction, Application and Specification
8.1.3 EMD Sereno Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Aytu BioScience
8.2.1 Aytu BioScience Male Infertility Treatment Production Sites and Area Served
8.2.2 Aytu BioScience Product Introduction, Application and Specification
8.2.3 Aytu BioScience Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer
8.3.1 Bayer Male Infertility Treatment Production Sites and Area Served
8.3.2 Bayer Product Introduction, Application and Specification
8.3.3 Bayer Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cadila
8.4.1 Cadila Male Infertility Treatment Production Sites and Area Served
8.4.2 Cadila Product Introduction, Application and Specification
8.4.3 Cadila Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Intas Pharma
8.5.1 Intas Pharma Male Infertility Treatment Production Sites and Area Served
8.5.2 Intas Pharma Product Introduction, Application and Specification
8.5.3 Intas Pharma Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Halotech DNA
8.6.1 Halotech DNA Male Infertility Treatment Production Sites and Area Served
8.6.2 Halotech DNA Product Introduction, Application and Specification
8.6.3 Halotech DNA Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 SCSA diagnostics
8.7.1 SCSA diagnostics Male Infertility Treatment Production Sites and Area Served
8.7.2 SCSA diagnostics Product Introduction, Application and Specification
8.7.3 SCSA diagnostics Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Andrology Solutions
8.8.1 Andrology Solutions Male Infertility Treatment Production Sites and Area Served
8.8.2 Andrology Solutions Product Introduction, Application and Specification
8.8.3 Andrology Solutions Male Infertility Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Male Infertility Treatment Market
9.1 Global Male Infertility Treatment Market Trend Analysis
9.1.1 Global Male Infertility Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Male Infertility Treatment Regional Market Trend
9.2.1 North America Male Infertility Treatment Forecast 2019-2025
9.2.2 Europe Male Infertility Treatment Forecast 2019-2025
9.2.3 China Male Infertility Treatment Forecast 2019-2025
9.2.4 Japan Male Infertility Treatment Forecast 2019-2025
9.2.5 Southeast Asia Male Infertility Treatment Forecast 2019-2025
9.2.6 India Male Infertility Treatment Forecast 2019-2025
9.3 Male Infertility Treatment Market Trend (Product Type)
9.4 Male Infertility Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Male Infertility Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

EMD Sereno、Aytu BioScience、Bayer、Cadila、Intas Pharma、Halotech DNA、SCSA diagnostics、Andrology Solutions

★調査レポート[世界の男性不妊治療市場 2019年] (コード:QYR20FB04098)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の男性不妊治療市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆